CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer 期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:  Ouyang, Xuenong;  Shi, Meiqi;  Jie, Fangwei;  Bai, Yuxian;  Shen, Peng
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial 期刊论文
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 卷号: 319, 期号: 24
作者:  Li, Jin;  Qin, Shukui;  Xu, Rui-Hua;  Shen, Lin;  Xu, Jianming
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017) 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 卷号: 11
作者:  Liu, Xinyang;  Qin, Shukui;  Wang, Zhichao;  Xu, Jianming;  Xiong, Jianping
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Liu, Xinyang;  Qin, Shukui;  Wang, Zhichao;  Xu, Jianming;  Xiong, Jianping
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Recombinant Human Endostatin and/or Cisplatin in Treatment of Malignant Hydrothorax and Ascites: A Multicenter Randomized Study 会议论文
作者:  Qin, Shukui;  Cheng, Ying;  Tan, Qinghe;  Bi, Jingwang;  Wang, Liwei
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Optimal regimen of trastuzumab in combination with oxaliplatin/capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/13
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2016, 卷号: 34, 期号: 13
作者:  Li, Jin;  Qin, Shukui;  Xu, Jianming;  Xiong, Jianping;  Wu, Changping
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/06
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 6
作者:  Li, Jin;  Qin, Shukui;  Xu, Ruihua;  Yau, Thomas C. C.;  Ma, Brigette
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13

©版权所有 ©2017 CSpace - Powered by CSpace